Molecular control for methicillin-resistant Staphylococcus aureus (MRSA) is used for rapid and high-precision MRSA colonization screening in specific population groups (nursing staff, patients with specific diseases, etc.).
Methicillin-resistant Staphylococcus aureus (Methicillin Resistant Staphylococcus aureus, MRSA) is a methicillin-resistant Staphylococcus aureus strain. Methicillin is an antibiotic commonly used to treat staphylococci. MRSA strains are mainly in hospitals and are responsible for increasing the length of stay in intensive care units. The mortality rate is high in transplant patients infected with MRSA strains after vascular surgery. MRSA strains that are found outside of hospitals (in the community) are highly infectious, grow faster and are genetically different from hospital strains. MRSA community strains can cause necrotic skin infections and necrotic pneumonia that can be fatal within 24 hours of its onset. Both MRSA strains are transmitted by the contact method. MRSA strains are also considered resistant to all cephalosporins and imipenem. Vancomycin is used to treat the strains.
This test is not used for the laboratory diagnosis of MRSA infection.
Laboratory test results are the most important parameter for the diagnosis and monitoring of all pathological conditions. 70%-80% of diagnostic decisions are based on laboratory tests. Correct interpretation of laboratory results allows a doctor to distinguish "healthy" from "diseased".
Laboratory test results should not be interpreted from the numerical result of a single analysis. Test results should be interpreted in relation to each individual case and family history, clinical findings and the results of other laboratory tests and information. Your personal physician should explain the importance of your test results.
At Diagnostiki Athinon we answer any questions you may have about the test you perform in our laboratory and we contact your doctor to get the best possible medical care.